Media Briefing: Ticks and Lyme Disease: Rising Numbers, How to Stay Safe, and New Research | Newswise

Media Briefing: Ticks and Lyme Disease: Rising Numbers, How to Stay Safe, and New Research | Newswise

Ticks and Lyme disease: Rising numbers, how to stay safe, and new research Newswise — As warmer temperatures bring more people outdoors—and more ticks into contact with humans—the Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media about ticks and the growing threat of Lyme and other tickborne diseases….

Read More
Media Briefing: Ticks and Lyme Disease: Rising Numbers, How to Stay Safe, and New Research | Newswise

Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With Type 1 Diabetes | Newswise

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient population, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. GLP-1 receptor agonists were developed more than two decades…

Read More
Media Briefing: Ticks and Lyme Disease: Rising Numbers, How to Stay Safe, and New Research | Newswise

Patients With Depression From Wealthier Areas More Likely to Use Telehealth for Mental Health Care | Newswise

Newswise — A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that mental health visits for patients with depression from high-wealth neighborhoods in Maryland were significantly more likely to happen via telehealth compared to patients with depression from low-wealth neighborhoods in Maryland from mid-2021 through mid-2024. Telehealth visits…

Read More